Scholarlink

<p>Monocyte-derived macrophages are central drivers of chronic renal inflammation and fibrosis, yet the regulatory mechanisms that restrain their profibrotic differentiation remain poorly defined. Here, we identified serine/threonine kinase 40 (STK40) as a suppressor of profibrotic macrophage differentiation and renal fibrosis progression. Myeloid-specific <i>Stk40</i> deletion exacerbated renal fibrosis in multiple mouse models. Single-cell RNA sequencing revealed expansion of Arg1⁺ macrophages in STK40-deficient kidneys. In vitro, STK40 restrained the differentiation of profibrotic Arg1⁺ macrophages in a constitutive photomorphogenic protein 1 (COP1)-dependent manner. Functionally, Arg1⁺ macrophages were potent extracellular matrix (ECM)-producing cells and promoted renal fibrosis both directly, through cell-intrinsic macrophage-to-myofibroblast transition (MMT), and indirectly, by inducing epithelial–mesenchymal transition (EMT). STK40 loss led to aberrant STAT3 activation, whereas pharmacological inhibition of STAT3 attenuated excessive profibrotic differentiation of STK40-deficient bone marrow-derived macrophages (BMDMs). Mechanistically, STK40 functioned as an adaptor linking COP1 and STAT3, thereby promoting STAT3 poly-ubiquitination. Finally, oral administration of an Arg1-targeted small-molecule inhibitor rescued renal fibrosis exacerbated by myeloid <i>Stk40</i> deficiency. These findings define an STK40–COP1–STAT3 axis that restrains profibrotic Arg1⁺ macrophage differentiation and identify Arg1⁺ macrophages as a potential therapeutic target for chronic kidney disease with progressive renal fibrosis.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

STK40 inhibits profibrotic Arg1+ macrophage differentiation and renal fibrosis by regulating poly-ubiquitination of STAT3

  • 期刊论文

  • 发表日期：

    2026年8月4日

查看全文
  • Jun Ni,
  • Jia Li,
  • Si-ying Sun,
  • Jia-min Liu,
  • Zhen-yan Jiang,
  • Yue-xiao Tao,
  • Hui-zi Wang,
  • Ge-ge He,
  • Seyedeh Sara Ahmadi Nishaboori,
  • Xin Li,
  • Xi-yu Liu,
  • Xue-zhu Li,
  • Zhe Ji,
  • Hui-yao Lan,
  • Dan-dan Zhang,
  • Xue-feng Wu

摘要

Monocyte-derived macrophages are central drivers of chronic renal inflammation and fibrosis, yet the regulatory mechanisms that restrain their profibrotic differentiation remain poorly defined. Here, we identified serine/threonine kinase 40 (STK40) as a suppressor of profibrotic macrophage differentiation and renal fibrosis progression. Myeloid-specific Stk40 deletion exacerbated renal fibrosis in multiple mouse models. Single-cell RNA sequencing revealed expansion of Arg1⁺ macrophages in STK40-deficient kidneys. In vitro, STK40 restrained the differentiation of profibrotic Arg1⁺ macrophages in a constitutive photomorphogenic protein 1 (COP1)-dependent manner. Functionally, Arg1⁺ macrophages were potent extracellular matrix (ECM)-producing cells and promoted renal fibrosis both directly, through cell-intrinsic macrophage-to-myofibroblast transition (MMT), and indirectly, by inducing epithelial–mesenchymal transition (EMT). STK40 loss led to aberrant STAT3 activation, whereas pharmacological inhibition of STAT3 attenuated excessive profibrotic differentiation of STK40-deficient bone marrow-derived macrophages (BMDMs). Mechanistically, STK40 functioned as an adaptor linking COP1 and STAT3, thereby promoting STAT3 poly-ubiquitination. Finally, oral administration of an Arg1-targeted small-molecule inhibitor rescued renal fibrosis exacerbated by myeloid Stk40 deficiency. These findings define an STK40–COP1–STAT3 axis that restrains profibrotic Arg1⁺ macrophage differentiation and identify Arg1⁺ macrophages as a potential therapeutic target for chronic kidney disease with progressive renal fibrosis.